Genmab — Januar 2018
-
Det er plausibelt. Det er i hvert fald ikke gennem Genmab aktien man får sin daglige spænding i disse dage.
-
You're absolutly right E L. It will be the right way - Japan will surprise with the sales.
-
or at least that's what im hoping
-
It's the best way. Short term I'm hoping - long term I know Genmab will be worth my investment.
-
Genmab-kandidat kan forbedre behandling af modermærkekræft
Et præklinisk studie foretaget af kræftforskere i Holland peger på, at en lægemiddelkandidat fra det danske biotekselskab Genmab kan være nøglen til at forbedre behandlingen af en særlig type modermærkekræft.
(medwatch.dk)
-
Genmab-topchef om ny gigantisk mulighed: Det ville ærlig talt ikke være første gang
Genmabs kræftguldæg Darzalex har vist potentiale på et helt nyt sygdomsområde - det måske største overhovedet. "Det kan sagtens ske, at Darzalex bliver større i en sygdom uden for kræftområdet," siger topchef Jan van de Winkel.
(medwatch.dk)
-
https://clinicaltrials.gov/ct2/show/N
CT02988817?term=genmab+axl&rank=1 -
-
short video from ASH on CENTAURUS trial: daratumumab monotherapy for smoldering multiple myeloma http://www.oncologytube.com/video/centaurus-trial-daratumumab-monotherapy-for-smoldering-multiple-myeloma/10003001
-
Gsk nåede faktisk at gennemføre eet fase 1 studie i sc ofa i RA. https://www.gsk-clinicalstudyregister.com/files2/b4e8bdcf-f58f-422c-943b-e8ccd3d0866c
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind